CFDE Data Portal | Search NFE4

	Label	Description
	NFE4 associations Collection (Entity type)	Associations for NFE4_associations
	NFE4 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	NFE4 Gene (Entity type)	ENSG00000230257 - nuclear factor, erythroid 4
	KFGENEBIN:NFE4-variant-count CUI gene has variants NFE4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Kids First
	GSE108464 AZ-628 1 v 15 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 14 v 15 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE205714 GSE229013 adenosine 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 7 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	KFGENEBIN:NFE4-variant-count CUI Kfgenebin (Entity type)	A Kfgenebin

NFE4 associations

Associations for NFE4_associations

NFE4 associations.tsv

A file from IDG as part of the Harmonizome project

NFE4

ENSG00000230257 - nuclear factor, erythroid 4

KFGENEBIN:NFE4-variant-count CUI gene has variants NFE4

A Knowledge Graph Assertion from Kids First

GSE108464 AZ-628 1 v 15 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 0 v 6 human up

A Gene Set from LINCS

GSE233679 nicotinamide 14 v 15 human up

A Gene Set from LINCS

GSE205714 GSE229013 adenosine 3 v 2 human dn

A Gene Set from LINCS

GSE239844 crizotinib 7 v 2 human dn

A Gene Set from LINCS

KFGENEBIN:NFE4-variant-count CUI

A Kfgenebin

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.